Core Viewpoint - The stock of Hui Sheng Biological-B (02627.HK) has shown strong performance over the past week, with a continuous upward trend in its share price [1] Price Performance - As of February 13, the stock closed at HKD 51.50, with a daily increase of 0.39% and a cumulative increase of 10.33% over the past five days, exhibiting a price fluctuation range of 12.47% [1] Fund Flow - There has been a continuous net inflow of main funds, with a net inflow of HKD 3.506 million on February 13 and a total net inflow of approximately HKD 9.1736 million over the past five days, indicating high institutional interest [2] Sector Comparison - In comparison to the biotechnology sector, which declined by 0.95%, and the Hang Seng Index, which fell by 1.72%, the company's stock price has demonstrated relative resilience [3]
中慧生物-B股价逆势上涨，近五日累计涨幅超10%